Смотреть фильмы онлайн

CLL - Data

   
- HD качество

Найдено 81189 видео
What's next in CLL?
Загружен 12 декабря 2018
Earn CME credit for a related activity: https://

B Cell Chronic Lymphocytic Leukemia: Strategies for Diagnosis, Prognosis, and Response to Therapy
Загружен 13 января 2015
Presentation 3 of 8 from the Mayo Clinic symposium, "Data-Driven Algorithms for Optimizing Laboratory Test Utilization for Hematologic Malignancies.

Expert Perspectives: Chronic Lymphocytic Leukemia (CLL)
Загружен 24 ноября 2015
Expert Perspectives was recorded at the conclusion of the chronic lymphocytic leukemia sessions on the second day of Lymphoma & Myeloma 2015: An ...

Ethnic, environmental, genetic, and familial risk factors for CLL
Загружен 12 декабря 2018
Earn CME credit for a related activity: https://

Update on Venetoclax for CLL
Загружен 12 февраля 2018
In this presentation from the Lymphoma & Myeloma 2017, Dr. Steven Coutre provides an update on the use of venetoclax for chronic lymphocytic leukemia ...

Debate: Is it appropriate to treat patients with CLL earlier in the era of novel agents? - No
Загружен 23 апреля 2017
In this presentation from the 2017 Great Debates & Updates in Hematologic Malignancies, Dr. Richard R. Furman argues that, in the era of novel agents, it is not ...

Debate: Optimal approach for the management of CLL patients with del(17p) - Ibrutinib
Загружен 16 апреля 2016
The continued evolution and refinement of strategies for disease diagnosis, risk assessment, therapeutic intervention and disease management have provided ...

Jennifer R. Brown, MD, PhD: The Changing Definition of “High-Risk” CLL
Загружен 17 сентября 2016
Jennifer R. Brown, MD, PhD, discusses how the definition of high-risk chronic lymphocytic leukemia has changed in the era of modern therapies and better ...

CLL-IPI: A New and Improved Staging System for CLL?
Загружен 18 июня 2015
In CLL, clinicians need better methods for deciding who to treat and how. Nadine Kutsch, MD, discusses the new CLL-International Prognostic Index (CLL-IPI), ...

Combination stifles CLL
Загружен 12 декабря 2013
The targeted therapy ibrutinib and the antibody rituximab knock down chronic lymphocytic leukemia in 90 % of patients in a clinical trial. Jan Burger, M.D., Ph.D., ...

CLL: Chemotherapy and Ibrutinib based regimens
Загружен 30 ноября 2014
Chronic lymphocytic leukemia (CLL) is the most common lymphoid malignancy in the western world and has a highly variable course. Advances in diagnosis ...

Highlight of CLL-related 2016 FDA approvals: Venetoclax
Загружен 10 ноября 2016
In this presentation from Lymphoma & Myeloma 2016, Dr. Richard R. Furman discusses the recent FDA approval of venetoclax for the treatment of chronic ...

CLL: Idelalisib based regimens
Загружен 30 ноября 2014
Chronic lymphocytic leukemia (CLL) is the most common lymphoid malignancy in the western world and has a highly variable course. Advances in diagnosis ...

Abstract: Single-agent Ibrutinib 420mg Induces Durable Responses in Patients with CLL
Загружен 24 ноября 2015
For the past fifteen years, Lymphoma & Myeloma has been the premier forum on the latest advances in lymphoma, myeloma, and other plasma cell neoplasms.

Deborah Simms interviews Dr. Brian Koffman about CLL data published at ASH 2018
Загружен 4 января 2019
Patient and advocate Deborah Simms interviews Dr. Brian Koffman, chief medical officer of the CLL society. Key points of this interview include: - New data on ...

 1 2 3 »  Последняя

Мир в онлайне